Long Island & Queens Vitreo Retinal Consultants, P.C.

08/05/2025

PYC Therapeutics is moving forward with a registrational trial for VP-001, a potential treatment for retinitis pigmentosa type 11, after receiving positive feedback from the FDA. Early studies have shown improvements in vision and retinal sensitivity, and the upcoming trial could bring this promising therapy one step closer to patients. Learn more: https://brnw.ch/21wUGW5

PYC Therapeutics advances VP-001 for retinitis pigmentosa, gaining FDA insights for its upcoming registrational trial.

08/01/2025

👁️ August is Children’s Eye Health & Safety Month - a vital reminder to keep a close eye on early warning signs of pediatric retinal disease.

From genetic conditions and prematurity-related issues to eye trauma, early detection is key. Be alert to symptoms like a white pupil in photos, eye misalignment, or any history of family vision loss.

Learn more about how we care for young eyes: https://brnw.ch/21wUBnG

07/31/2025

Dr. Brett J. Rosenblatt brings a rare combination of advanced surgical expertise and deeply personalized care to every patient he sees. Fellowship-trained at Barnes Retina Institute and a former Chief Resident at Wills Eye Hospital, he specializes in treating retinal detachment, macular degeneration, diabetic retinopathy, and more. Dr. Rosenblatt is currently accepting new patients in Hauppauge and Riverhead. 👁️ Learn more: https://brnw.ch/21wUA2O

07/29/2025

VeonGen Therapeutics (formerly ViGeneron) has received FDA Rare Pediatric Disease Designation for VG801, a gene therapy targeting Stargardt disease and related retinal disorders. This innovative treatment delivers the full ABCA4 gene, offering new hope for children with rare inherited vision loss. Learn more: https://brnw.ch/21wUwcG

VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for Stargardt disease and related retinal disorders.

07/24/2025

ZEISS CLARUS 700 has received approval in China, bringing advanced retinal imaging to eye care providers. With ultra-widefield, high-resolution images and AI-enhanced tools, this device helps doctors diagnose and monitor retinal diseases more precisely than ever. Learn more: https://brnw.ch/21wUp8B

CLARUS 700, the advanced retinal imaging system, captures 133 degrees in a single image and up to 267 degrees with multiple images.

07/21/2025

With over 4,000 five-star reviews, Dr. Vincent A. Deramo is a trusted leader in retinal care and a pillar of excellence at VRCNY. He also currently serves as Chief of Ophthalmology at North Shore University Hospital in Syosset. His contributions to research, education, and patient care continue to shape the future of ophthalmology. 👁️👏 Learn more: https://brnw.ch/21wUjHD

07/18/2025

Last week, Dr. Albert Li delivered an insightful and impactful community talk at the Flushing Library.

Hosted in partnership with the Association of Chinese American Physicians and Queens Public Library, this event helped to empower seniors with vital information on protecting their vision and maintaining independence.

07/17/2025

Thank you, Esther, for trusting us with your care over the years. Loyalty like this speaks volumes - and so does Dr. Fastenberg’s commitment to excellence!

07/16/2025

Vitreoretinal Consultants of NY is proud to be a sponsor of the 2025 Flushing BID (Business Improvement District) Health Fair! 🏥✨

Join us this Saturday, July 19th from 11 AM – 2 PM on 40th Road between Main St. and Prince St. in Downtown Flushing. Stop by to learn about retinal health and meet Dr. Albert Li, retina specialist and surgeon. This annual event brings the community together to promote wellness, prevention, and access to essential care.

07/15/2025

Gore has launched a new silicone-free 0.5-mL IMPROJECT plunger for eye injections, helping reduce risks like floaters, inflammation, and high eye pressure linked to silicone. This new design meets strict safety standards and could make treatments even safer for patients receiving retinal and ophthalmic medications. Learn more: https://brnw.ch/21wUaFt

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

07/10/2025

NIH scientists have developed a new surgical technique that allows multiple tissue grafts to be placed in the retina, offering new hope for patients with dry AMD. The new method helps protect surrounding tissue during surgery and could improve outcomes by better preserving vision. Learn more: https://brnw.ch/21wU3rH

The new surgical technique incorporates a new surgical clamp that maintains eye pressure during the insertion of 2 tissue patches in immediate succession while minimizing damage to the surrounding tissue.

07/08/2025

We are proud to celebrate Dr. Philip J. Ferrone on achieving 20 consecutive years as a Castle Connolly Top Doctor - a testament to his unwavering excellence in retina care. From Harvard to Duke to decades of groundbreaking research and surgical innovation, Dr. Ferrone continues to set the highest standard in the field. 👏🏽🏅